CMS Episodes
Sept. 26, 2023
CMS Drug Price Negotiations
Kirsten Axelsen, Senior Policy Advisor at DLA Piper, says some of the fallout from CMS announcing price controls is already happening; the E&C Oversight and Investigations Subcommittee held a hearing on the IRA’s price-setting; and Patients...
None
July 6, 2023
Home Health Hiccup + Rare Disease Priorities
Joanne Cunningham, CEO of the Partnership for Quality Home Healthcare, discusses the robust support for home health even as CMS aims to cut funding; Jeffrey Oldham, Director of State Government Relations and Advocacy for the Rare Access Action...
None
June 8, 2023
CMS' New Power
The Patient Access and Affordability Project, a program of Patients Rising, releases principles for CMS to harness the power of patients as the agency implements the Inflation Reduction Act; CMS is foregoing some of the normal requirements for...
None
April 20, 2023
Alzheimer’s Treatments Restricted, Expanding Primary Care
The House Energy and Commerce Health Subcommittee considers extending several bills, including those that would bolster primary care services; Sue Peschin, the President of the Alliance for Aging Research, examines how CMS has been using Coverage with...
None
April 6, 2023
Discriminatory Health Metrics, Inclusive VA Healthcare
Neal Masia, Health Economist and Columbia University Professor of Business and Economics, discusses how the QALY discriminates against rare and chronic disease patients and calls for a more patient-focused health technology assessment; the Jax Act,...
None